Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

CROs Urge for Modernization of Clinical Trials

May 2, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.

Some Supply Chain Lessons Can Go a Long Way towards Success

May 2, 2012

Pharmaceutical Technology

Apple's experience with manufacturing facilities in China present opportunity for future best practice.

Channeling Steve Jobs

May 2, 2012

Pharmaceutical Technology

Service providers must focus on delivering a superior customer experience.

Ways to Recover Lost Margins

May 2, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Recovery audits and other past practices in procurement can improve the bottom line.

Report from Poland

May 2, 2012

Pharmaceutical Technology

Poland's government aims to make the Eastern European country a biotech powerhouse.

Bioprocessing Trends: Annual Survey Results

May 1, 2012

Pharmaceutical Technology

Readers share their views on bioprocessing challenges, equipment use, and outsourcing trends in our annual bioprocessing equipment and processing survey.

Inside INFORMEX: Evaluating the Market for Contract API Manufacturing

April 2, 2012

Pharmaceutical Technology

Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.

Q&A with Erik van den Berg, AM-Pharma

April 2, 2012
Pharmaceutical Technology

A Q&A with Erik van den Berg, CEO of AM-Pharma, on recent industry trends.

Ways to Recover Lost Margins

April 2, 2012

Pharmaceutical Technology

Recovery audits and other past practices in procurement can improve the bottom line.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here